FEATURED NEWS

• HDA Statement in Opposition of New York State Opioid Tax

  March 30, 2018

  HDA President and CEO John M. Gray released the following statement after the passage of the 2019 New York State budget.

• Smith Drug Company Receives Distribution Management Award for Implementation of Cloud-Based Predictive Inventory Management System

  March 6, 2018

  Smith Drug Company, Div. J M Smith Corporation, has received the Healthcare Distribution Alliance’s (HDA) 2018 Distribution Management Award (DMA) for their implementation of a cloud-based predictive inventory management system (IMS). The award was presented at HDA’s Distribution Management Conference and Expo in Austin, Texas.

• HDA Recognizes Dianne Pfahl of Cardinal Health with Distribution Management Award for Industry Leadership

  March 6, 2018

  The Healthcare Distribution Alliance (HDA) has honored Dianne Pfahl, Vice President, Strategic Sourcing National Brands, Cardinal Health, Inc., with the 2018 Distribution Management Award (DMA) for Industry Leadership. The award was presented at HDA’s Distribution Management Conference and Expo in Austin, Texas.

• HDA Statement on Review of Annual Production Quotas for Opioids

  March 2, 2018

  HDA President and CEO John M. Gray released the following statement in response to Attorney General Jeff Sessions' recent memo regarding opioid production quotas.

• HDA Statement on Department of Justice Opioid Efforts

  February 27, 2018

  Today, Healthcare Distribution Alliance (HDA) President and CEO John M. Gray issued a statement in response to new efforts by the Department of Justice to address the opioid epidemic.